Clinical Trials for Cystic Fibrosis
Researchers around the world are working to develop new drugs for the treatment of cystic fibrosis. These new treatments must go through a rigorous trial process, testing their safety and efficacy, before they are made available to the people who need them. Patients play a critical role in the development of new treatments through their participation in these clinical trials.
Below are ongoing clinical trials for cystic fibrosis that have been organized into various categories by the Cystic Fibrosis Foundation.
|VX-809 + ivacaftor||1||1||2||0||4|
|VX-661 + ivacaftor||0||2||0||0||2|
|Restore Airway Surface Liquid|
|Alpha 1 Anti-Trypsin||0||1||0||0||1|
Phase 4 or compassionate care study
** Only ongoing studies are included (recruiting, pending recruitment or active, but not yet recruiting)